Cava Healthcare Inc. has announced that it has entered into an agreement to sell its right, title and interest in and the intellectual property rights for use of psychedelics to treat dementia to Mynd Life Sciences Inc..
Category Press Release
Cava Healthcare Inc. has announced that it has entered into an agreement to sell its right, title and interest in and the intellectual property rights for use of psychedelics to treat dementia to Mynd Life Sciences Inc..